Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-06-08 @ 4:43 PM
Study NCT ID:
NCT02503358
Status:
COMPLETED
Last Update Posted:
2023-03-21
First Post:
2015-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Sponsor:
OHSU Knight Cancer Institute
Organization: